
Gliclazide (30mg) + Metformin (500mg)
Active composition
+1 more active ingredient
Gliclazide stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Glychek-M OD 30mg/500mg Tablet is a combination oral hypoglycemic agent containing Gliclazide 30mg and Metformin 500mg, indicated for the management of type 2 diabetes mellitus. Gliclazide, a sulfonylurea class drug, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, contributing to better glucose uptake and utilization. The once-daily formulation of Glychek-M OD facilitates patient compliance and sustained glycemic control throughout the day. This combination is particularly beneficial for patients inadequately controlled on diet and exercise alone or those requiring dual therapy to achieve target blood glucose levels. Glychek-M OD should be used as part of a comprehensive diabetes management plan including diet, exercise, and regular monitoring of blood glucose levels. Caution is advised in patients with renal or hepatic impairment, and it is contraindicated in cases of diabetic ketoacidosis or severe infections. Common adverse effects may include gastrointestinal disturbances and hypoglycemia; therefore, patient education on recognizing symptoms is essential. Regular follow-up and laboratory assessments are recommended to optimize therapy and minimize potential risks.
How to use Glychek-M Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glychek-M OD 30mg/500mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glychek-M OD 30mg/500mg Tablet.
High Risk
Glychek-M OD 30mg/500mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glychek-M OD 30mg/500mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glychek-M OD 30mg/500mg Tablet may be needed. Please consult your doctor. Glychek-M OD 30mg/500mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Glychek-M OD 30mg/500mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Glychek-M OD 30mg/500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glychek-M OD 30mg/500mg Tablet may be needed. Please consult your doctor. Use of Glychek-M OD 30mg/500mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Glychek-M OD 30mg/500mg Tablet

Gliclazide (30mg) + Metformin (500mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Gliclazide stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Glychek-M OD 30mg/500mg Tablet is a combination oral hypoglycemic agent containing Gliclazide 30mg and Metformin 500mg, indicated for the management of type 2 diabetes mellitus. Gliclazide, a sulfonylurea class drug, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, contributing to better glucose uptake and utilization. The once-daily formulation of Glychek-M OD facilitates patient compliance and sustained glycemic control throughout the day. This combination is particularly beneficial for patients inadequately controlled on diet and exercise alone or those requiring dual therapy to achieve target blood glucose levels. Glychek-M OD should be used as part of a comprehensive diabetes management plan including diet, exercise, and regular monitoring of blood glucose levels. Caution is advised in patients with renal or hepatic impairment, and it is contraindicated in cases of diabetic ketoacidosis or severe infections. Common adverse effects may include gastrointestinal disturbances and hypoglycemia; therefore, patient education on recognizing symptoms is essential. Regular follow-up and laboratory assessments are recommended to optimize therapy and minimize potential risks.
How to use Glychek-M Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glychek-M OD 30mg/500mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glychek-M OD 30mg/500mg Tablet.
High Risk
Glychek-M OD 30mg/500mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glychek-M OD 30mg/500mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glychek-M OD 30mg/500mg Tablet may be needed. Please consult your doctor. Glychek-M OD 30mg/500mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Glychek-M OD 30mg/500mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Glychek-M OD 30mg/500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glychek-M OD 30mg/500mg Tablet may be needed. Please consult your doctor. Use of Glychek-M OD 30mg/500mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Glychek-M OD 30mg/500mg Tablet













